Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study

Viswanathan MohanKyu Jeung AhnYoung Min ChoRakesh Kumar SahayChien-Ning HuangSanjay KalraManoj ChadhaIndranil BhattacharyaSo Yeon KimErik Spaepen2026-01-292026-01-292019-05-2210.1007/s40261-019-00798-1https://scholars.csmu.edu.tw/handle/123456789/3853[SDGs]SDG3Lilly Insulin Glargine Versus Lantus® in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Studyjournal-article